Age restrictions on inhaled corticosteroid (ICS) + long-acting beta2 agonist (LABA) fixed dose combination (FDC) products Correspondence from Clinician Page last updated: 30 June 2020 Public Summary Document (PSD) December 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) December 2019 PBAC Meeting - (Word 181KB)